Where does Eikon Therapeutics, Inc.
's balance sheet data come from?

Question

Accepted Answer

Every line is extracted from Eikon Therapeutics, Inc.
's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

	Q1 '26	Q4 '25	Q1 '25
Cash and cash equivalents	$161.15M-21.2%	$104.9M—	$204.58M—
Short-term investments	$351.03M—	$231.07M—	——
Total current assets	$529.5M—	$348.92M—	——
Property and equipment, net	$138.07M—	$142.9M—	——
Total assets	$850.83M—	$594.73M—	——
Accounts payable	$6.01M+164%	$681K—	$2.28M—
Total current liabilities	$45.06M—	$55.01M—	——
Total liabilities	$300.16M—	$312.3M—	——
Retained earnings	-$1B—	-$920.51M—	——
Total stockholders' equity	$550.67M+186%	-$879.03M-53.7%	-$640.14M—
Total liabilities and stockholders' equity	$850.83M—	$594.73M—	——

Eikon Therapeutics, Inc. EIKN Balance Sheet Statement

Questions, answered.